Jacobs Designs and Builds Award-Winning Facility for Novartis

PASADENA, Calif.--(BUSINESS WIRE)-- Jacobs Engineering Group Inc. (NYSE:JEC) announced today that a project it executed on behalf of Novartis received the 2013 Facility of the Year Award (FOYA) from the International Society for Pharmaceutical Engineering (ISPE), INTERPHEX and Pharmaceutical Processing magazine, sponsors of the awards program.

The U.S. Flu Cell Culture Facility at the Novartis Campus in Holly Springs, N.C. uses an innovative cell culture technology to manufacture seasonal and pandemic influenza vaccines. Judges cited the creative solution of containment convertibility that allows the facility to run at lower levels to reduce operating costs during routine seasonal influenza production, yet still maintain the capability of operating at higher containment levels when required. Jacobs provided design services, engineering, procurement, and construction management for the facility.

In making the announcement, Jacobs Group Vice President Chris Nagel stated, “It was an honor to work alongside Novartis and help meet their vaccine manufacturing needs for patients worldwide. We appreciate the trust they place in us and are very pleased that we were able to contribute to this award-winning project.”

The FOYA program recognizes pharmaceutical manufacturing projects that use new and innovative technologies to enhance project delivery and reduce production costs of high quality medicines for the benefit of all global consumers. This is the second consecutive year that Jacobs worked on the winning project.

Jacobs is one of the world's largest and most diverse providers of technical professional and construction services.

This project has been funded in whole or in part with Federal funds from the Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under contract No. HHS0100200900101C.

Statements made in this release that are not based on historical fact are forward-looking statements. We base these forward-looking statements on management’s current estimates and expectations as well as currently available competitive, financial and economic data. Forward-looking statements, however, are inherently uncertain. There are a variety of factors that could cause business results to differ materially from our forward-looking statements. For a description of some of the factors which may occur that could cause actual results to differ from our forward-looking statements please refer to our 2013 Form 10-K, and in particular the discussions contained under Items 1 - Business, 1A - Risk Factors, 3 - Legal Proceedings, and 7 - Management's Discussion and Analysis of Financial Condition and Results of Operations. We do not undertake to update any forward-looking statements made herein.

Source: Jacobs Engineering Group Inc.

Jacobs Engineering Group Inc.

Michelle Jones, 626-578-6968